MBS 303 - AdisInsht - Springer
mbs303MBS303 is a CD20×CD3 T-cell-engaging bispecific antibody that has a novel 2:1 (CD20:CD3) confuration to kill malnant B cells. This dose-escalation phase Ⅰ trialmbs303cd3cd20t MBS303
IDR 10.000
IDR 100.000
Disc -90%